Interactive Research And Development: Clinical Trials

2 trials sponsored by Interactive Research And Development, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Interactive Research And Development: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
Bedaquiline 100 MG, Delamanid 50 MG Oral Tablet, Clofazimine 100 MG Oral Capsule - Tuberculosis, Multidrug-Resistant, Tuberculosis
Phase 3CompletedMédecins Sans Frontières, France3232020-04-062025-02-10
Evaluating Newly Approved Drugs for Multidrug-resistant TB
Bedaquiline, Delamanid, Clofazimine - Tuberculosis, Multidrug-Resistant, Infection, Bacterial
Phase 3CompletedMédecins Sans Frontières, France7542016-12-012025-02-10

Conditions studied

Bacterial Infections (2)  ·  Tuberculosis (2)  ·  Tuberculosis, Multidrug-Resistant (2)  ·  Tuberculosis, Pulmonary (2)  ·  Extensively Drug-Resistant Tuberculosis (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Mycobacterium Infections (1)

Interventions

Clofazimine (2)  ·  Linezolid (2)  ·  OPC-67683 (2)  ·  bedaquiline (2)  ·  Levofloxacin (1)  ·  Moxifloxacin (1)  ·  Pyrazinamide (1)  ·  Tablets (1)

Countries

India (2)  ·  Kazakhstan (2)  ·  Lesotho (2)  ·  Pakistan (2)  ·  Peru (2)  ·  Georgia (1)  ·  South Africa (1)  ·  Vietnam (1)

Top investigators

Carole Mitnick, Sc.D (2)  ·  Lorenzo Guglielmetti, MD (2)

Results publications

PMID 31676905, PMID 34563240, PMID 35028659, PMID 38037119, PMID 39879593, PMID 40683298